- $12.99m
- $10.93m
- $16.56m
- 70
- 33
- 41
- 45
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 10.5 | 12.9 | 14.9 | 16.6 | 16.6 |
Cost of Revenue | |||||
Gross Profit | 2.75 | 3.11 | 3.45 | 3.69 | 3.79 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 11.3 | 15.1 | 15.4 | 16.5 | 17.2 |
Operating Profit | -0.712 | -2.13 | -0.49 | 0.059 | -0.588 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.28 | -2.11 | -0.49 | 0.196 | 0.261 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.282 | -2.23 | -0.697 | 0.652 | 0.353 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.282 | -2.23 | -0.697 | 0.652 | 0.353 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.09 | -2.26 | -0.697 | 0.652 | 0.353 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.054 | -0.413 | -0.094 | 0.084 | 0.044 |